Neuropace Inc (NPCE)

R&D Expense Growth

-4.05%

Quarterly · Period ending:

NPCE logo

NPCE R&D Expense Growth

Latest reported-4.05%
NPCE Quarterly R&D Growth (QoQ) (0.00% → -4.05%)
High-resolution chart · PNG

NPCE r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Neuropace Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-4.0479%
2.3054%
6.8583%
-3.9299%
-7.9973%
22.9752%
5.1442%
-5.1278%
4.8582%
7.5693%
12.1376%
-10.2564%
1.52%
3.4191%
-9.3032%
-1.0231%
1.6496%
4.3405%
23.4696%
-2.4341%
8.2195%
4.6185%
6.1772%
13.4994%
-32.7126%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.